Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

被引：9
|
作者：
Warner, Ben [1 ]
Harris, Adam W. [1 ]
机构：
[1] Tunbridge Wells Hosp Pembury, Dept Gastroenterol, Pembury, Kent, England
来源：
GASTROENTEROLOGY | 2012年 / 143卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2012.03.055
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [1] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal B.
    [J]. GASTROENTEROLOGY, 2012, 142 (02) : 257 - +
  • [2] Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Van Assche, Gert A.
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert R.
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S123 - S124
  • [3] Induction and maintenance of clinical remission by adalimumab in patients with moderate-to-severe Ulcerative Colitis
    Sandborn, William
    Van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas
    Kron, Martina
    Tighe, Mary
    Lazar, Andreas
    Thakkar, Roopal
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S3 - S4
  • [4] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    [J]. GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [5] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Feagan, Brian G.
    Schreiber, Stefan
    Wolf, Douglas C.
    Axler, Jeffrey L.
    Kaviya, Arpeat
    James, Alexandra
    Curtis, Rebecca I.
    Geransar, Parnia
    Stallmach, Andreas
    Ehehalt, Robert
    Bokemeyer, Bernd
    Khalid, Javaria Mona
    O'Byrne, Sharon
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1028 - 1035
  • [6] Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Rutgeerts, Paul
    [J]. GASTROENTEROLOGY, 2014, 146 (01) : 96 - +
  • [7] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Toruner, Murat
    Jonaitis, Laimas
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1215 - 1226
  • [8] Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis
    Tribich, Samuel
    Maurice, James
    [J]. FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 173 - 173
  • [9] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    O'Connor, Donal B.
    Lahiff, Conor
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 92 - 93
  • [10] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis REPLY
    Sands, Bruce E.
    Schreiber, Stefan
    Lirio, Richard A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 93 - 94
12345